1. Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome;Bergstein;N Engl J Med,1992
2. Clearance of 131I by hemodialysis;Culpepper;Clin Nephrol,1992
3. Creatine phosphokinase increase during dialysis by red-cell fragmentation;Hombrouckx;Nephrol Dial Transplant,1992
4. Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients;Verpooten;Nephrol Dial Transplant,1992
5. Hematologic parameters and iron stores in patients on hemodialysis for chronic renal failure;Nuwayri-Salti;Clin Nephrol,1992